본문으로 건너뛰기
← 뒤로

Explainable federated transformer framework for joint leukemia classification and stage prediction.

Scientific reports 2026 Vol.16(1) p. 4493

Parwez K, Sohail SI, Akram A, Rashid J, Atteia G, Sarwar N

📝 환자 설명용 한 줄

The diagnosis of leukemia is based on the simultaneous analysis of morphological patterns of hematological images and the presence of clinical indicators in written reports.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Parwez K, Sohail SI, et al. (2026). Explainable federated transformer framework for joint leukemia classification and stage prediction.. Scientific reports, 16(1), 4493. https://doi.org/10.1038/s41598-025-34715-8
MLA Parwez K, et al.. "Explainable federated transformer framework for joint leukemia classification and stage prediction.." Scientific reports, vol. 16, no. 1, 2026, pp. 4493.
PMID 41486186

Abstract

The diagnosis of leukemia is based on the simultaneous analysis of morphological patterns of hematological images and the presence of clinical indicators in written reports. Majority of machine learning models are unimodal and centralized. They are not able to integrate information with the institutions or give clinically useful explanations. This paper suggests a federated multimodal architecture that integrates Vision Transformers (ViT) and ClinicalBERT to encode images and classify texts to conduct joint leukemia diagnosis and staging in decentralized medical devices, respectively. Both modalities are synthesised into a single semantic space to form a cross-modal fusion layer, and binary diagnosis and multiclass staging are facilitated by dual output heads. The framework uses federated learning protocol which maintains the privacy of data by the fact that the local data does not move out of institutional boundaries. To improve the level of transparency, SHAP-based explanations are provided on each prediction, where both visual regions and clinical tokens are considered important. The results of the experiments indicate that the suggested system is more accurate and has a higher F1-score than unimodal and centralized baselines and also has interpretable and patient-specific explanation, which is consistent with clinical expectations. The architecture is robust in the non-IID data distributions and is scaled through simulated healthcare networks, which makes it appropriate to deploy to actual health care in diagnostic oncology.

MeSH Terms

Humans; Leukemia; Machine Learning; Neoplasm Staging